Shu YQ - Search Results

1

The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer.

Wang RS, Liu LX, Gu YH, Lin QF, Guo RH, Shu YQ. Wang RS, et al. Among authors: shu yq. Biomed Pharmacother. 2010 May;64(5):309-12. doi: 10.1016/j.biopha.2009.09.011. Epub 2009 Nov 5. Biomed Pharmacother. 2010. PMID: 19942398

2

The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers.

Shu YQ, Gu Y. Shu YQ, et al. Biomed Pharmacother. 2006 May;60(4):156-60. doi: 10.1016/j.biopha.2006.03.001. Epub 2006 Mar 31. Biomed Pharmacother. 2006. PMID: 16647239

3

[Immunomodulatory effects of spleenic cells added by sIL-15Ralpha on the regulation of melanoma cell growth].

Gu YH, Wang RS, Shu YQ, Xu Q. Gu YH, et al. Among authors: shu yq. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Sep;24(9):847-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008. PMID: 18782512 Chinese.

4

Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells.

Wu H, Li W, Wang T, Shu Y, Liu P. Wu H, et al. Biomed Pharmacother. 2008 Nov;62(9):659-66. doi: 10.1016/j.biopha.2008.08.002. Epub 2008 Aug 31. Biomed Pharmacother. 2008. PMID: 18809274

5

Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.

Shen H, Gao W, Wu YJ, Qiu HR, Shu YQ. Shen H, et al. Among authors: shu yq. Biomed Pharmacother. 2009 Jul;63(6):396-403. doi: 10.1016/j.biopha.2008.08.010. Epub 2008 Sep 16. Biomed Pharmacother. 2009. PMID: 18848758

6

A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.

Gu Y, Shu Y, Xu Q. Gu Y, et al. Biomed Pharmacother. 2009 May;63(4):293-6. doi: 10.1016/j.biopha.2008.08.018. Epub 2008 Sep 17. Biomed Pharmacother. 2009. PMID: 18848761 Clinical Trial.

7

Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.

Guo R, Huang Z, Shu Y, Jin S, Ge H. Guo R, et al. Biomed Pharmacother. 2009 Jun;63(5):375-9. doi: 10.1016/j.biopha.2008.09.010. Epub 2008 Oct 23. Biomed Pharmacother. 2009. PMID: 18993026

8

The property of methylated APC gene promotor and its influence on lung cancer cell line.

Pan S, Zhang L, Gao L, Gu B, Wang F, Xu J, Shu Y, Yang D, Chen Z. Pan S, et al. Biomed Pharmacother. 2009 Aug;63(7):463-8. doi: 10.1016/j.biopha.2008.09.006. Epub 2008 Oct 23. Biomed Pharmacother. 2009. PMID: 18996677

9

CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.

Zhu BQ, Ju SW, Shu YQ. Zhu BQ, et al. Among authors: shu yq. Biomed Pharmacother. 2009 Aug;63(7):509-16. doi: 10.1016/j.biopha.2008.10.003. Epub 2008 Oct 31. Biomed Pharmacother. 2009. PMID: 19019623

10

[Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells].

Guo RH, Jin SD, Cai J, Huang ZH, Shu YQ. Guo RH, et al. Among authors: shu yq. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):745-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173802 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters